HK1046642B - 新的二苯乙烯化合物 - Google Patents

新的二苯乙烯化合物 Download PDF

Info

Publication number
HK1046642B
HK1046642B HK02108244.5A HK02108244A HK1046642B HK 1046642 B HK1046642 B HK 1046642B HK 02108244 A HK02108244 A HK 02108244A HK 1046642 B HK1046642 B HK 1046642B
Authority
HK
Hong Kong
Prior art keywords
compound
rats
compounds
diabetes
insulin
Prior art date
Application number
HK02108244.5A
Other languages
English (en)
Chinese (zh)
Other versions
HK1046642A1 (en
Inventor
B‧纳格
B‧納格
S‧麦迪彻拉
D‧戴
S‧麥迪徹拉
Original Assignee
卡里克斯治疗公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 卡里克斯治疗公司 filed Critical 卡里克斯治疗公司
Publication of HK1046642A1 publication Critical patent/HK1046642A1/xx
Publication of HK1046642B publication Critical patent/HK1046642B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/40—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals
    • C07C15/50—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals polycyclic non-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK02108244.5A 1999-05-18 1999-05-18 新的二苯乙烯化合物 HK1046642B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/011001 WO2000069430A1 (en) 1999-05-18 1999-05-18 Novel diphenylethylene compounds

Publications (2)

Publication Number Publication Date
HK1046642A1 HK1046642A1 (en) 2003-01-24
HK1046642B true HK1046642B (zh) 2005-11-25

Family

ID=22272785

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02108244.5A HK1046642B (zh) 1999-05-18 1999-05-18 新的二苯乙烯化合物

Country Status (9)

Country Link
EP (1) EP1178788A4 (enrdf_load_stackoverflow)
JP (1) JP2002544227A (enrdf_load_stackoverflow)
KR (1) KR100598638B1 (enrdf_load_stackoverflow)
CN (1) CN1194674C (enrdf_load_stackoverflow)
AU (1) AU778767C (enrdf_load_stackoverflow)
CA (1) CA2373603A1 (enrdf_load_stackoverflow)
HK (1) HK1046642B (enrdf_load_stackoverflow)
MX (1) MXPA01011760A (enrdf_load_stackoverflow)
WO (1) WO2000069430A1 (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323496B2 (en) 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
CN100484400C (zh) * 2000-02-04 2009-05-06 卡里克斯治疗公司 二苯基乙烯化合物
US6552085B2 (en) * 2000-08-16 2003-04-22 Insmed Incorporated Compositions containing hypoglycemically active stilbenoids
US6410596B1 (en) * 2000-08-16 2002-06-25 Insmed Incorporated Compositions containing hypoglycemically active stillbenoids
CN1398838A (zh) * 2001-07-26 2003-02-26 中国人民解放军军事医学科学院放射医学研究所 二苯乙烯类化合物制备以及它们在治疗和预防糖尿病中的应用
JP4781580B2 (ja) * 2001-09-26 2011-09-28 日本メナード化粧品株式会社 コラゲナーゼ阻害剤
US20050096256A1 (en) 2003-07-01 2005-05-05 President And Fellows Of Harvard College Compositions for manipulating the lifespan and stress response of cells and organisms
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
CA2548671C (en) 2003-12-29 2015-02-24 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
CN1723884A (zh) * 2004-07-21 2006-01-25 中国人民解放军军事医学科学院放射医学研究所 顺式－1，2－取代的二苯乙烯衍生物用于制备治疗或预防糖尿病的药物的用途
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
CN100384801C (zh) * 2006-06-23 2008-04-30 中国科学院广州化学研究所 (e)-3,5-二甲氧基-4＇-羟基二苯乙烯的合成方法
FR2904311B1 (fr) 2006-07-28 2013-01-11 Clariant Specialty Fine Chem F Nouveau procede de synthese de derives (e) stilbeniques perm permettant d'obtenir le resveratrol et le piceatannol
FR2921921B1 (fr) 2007-10-03 2011-08-19 Clariant Specialty Fine Chem F Procede de synthese de composes polyhydroxystilbeniques.
CN107324976B (zh) * 2017-07-28 2020-06-16 安徽理工大学 一种制备(E)-β-烷基苯乙烯类化合物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314693A (en) * 1992-02-07 1994-05-24 Kioritz Corporation Pest control chemicals against pine wood nematodes
US5430062A (en) * 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
US5770620A (en) * 1995-06-19 1998-06-23 Ontogen Corporation Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures

Also Published As

Publication number Publication date
MXPA01011760A (es) 2003-09-04
CA2373603A1 (en) 2000-11-23
AU778767C (en) 2006-09-07
KR100598638B1 (ko) 2006-07-07
AU4085799A (en) 2000-12-05
CN1194674C (zh) 2005-03-30
CN1354659A (zh) 2002-06-19
EP1178788A4 (en) 2005-08-10
AU778767B2 (en) 2004-12-23
WO2000069430A1 (en) 2000-11-23
JP2002544227A (ja) 2002-12-24
KR20020012220A (ko) 2002-02-15
HK1046642A1 (en) 2003-01-24
EP1178788A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
US6245814B1 (en) Diphenylethylene compounds
HK1046642A1 (en) Novel diphenylethylene compounds
US8044243B2 (en) Compounds for the treatment of metabolic disorders
CN1750758B (zh) 用于治疗代谢紊乱的化合物
AU2004229418B2 (en) Compounds for the treatment of metabolic disorders
US6624197B1 (en) Diphenylethylene compounds
AU2004237602B2 (en) Compounds for the treatment of metabolic disorders
US6448450B1 (en) 1-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)-ethylene for diabetes treatment
CA2390276A1 (en) Novel compounds to treat diabetes and associated conditions
KR101391905B1 (ko) 물질대사 장애의 치료용 화합물
US7005539B2 (en) Ferulic acid dimers and their pharmaceutically acceptable salts, their preparation and use thereof for treating dementia
CA2487165C (en) Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
AU784974B2 (en) Novel diphenylethylene compounds
NZ511065A (en) Diphenylethylene (stillbenzenes) compounds for treating diabetes
DE69200810T2 (de) Benzoesäureethanolaminesterderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
JP2011509942A (ja) 代謝異常の治療のための化合物

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090518